The news releases are issued by FUJIFILM Corporation in Japan.
Fujifilm makes no representation that products on these news releases are commercially available in all countries and regions.
Please note that contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.
- Sep 30, 2021
- Fujifilm establishes the Advanced Materials Strategy Headquarters
- Sep 27, 2021
- Fujifilm’s portable X-ray system “FDR Xair System” obtains recommendation from the Stop TB Partnership as an X-ray device for tuberculosis screening
- Sep 22, 2021
- The premium compact digital camera “FUJIFILM X100V” wins Bronze Award in the internationally-prestigious U.S. design award, IDEA
- Sep 9, 2021
- Fujifilm launches a project for verifying the effectiveness of AI technology assisting diagnostic imaging in health screening services in India
- Sep 7, 2021
-
Fujifilm Launches LTO Ultrium9 Data Cartridge
-Magnetic tape storage media with maximum storage capacity of 45TB
-Providing safe long-term storage of high-volume data at low cost
-Significantly mitigating CO2 emissions - Sep 2, 2021
- Fujifilm launches mirrorless digital camera “FUJIFILM GFX50S II”
- Sep 2, 2021
- Fujifilm launches FUJINON Lens GF35-70mmF4.5-5.6 WR
- Sep 2, 2021
- Fujifilm unveils the latest development roadmap for interchangeable lenses for the GFX Series of mirrorless digital cameras
- Sep 2, 2021
- Fujifilm launches mirrorless digital camera “FUJIFILM X-T30 II”
- Sep 2, 2021
- Fujifilm launches FUJINON Lens XF23mmF1.4 R LM WR
- Sep 2, 2021
- Fujifilm launches FUJINON Lens XF33mmF1.4 R LM WR
- Sep 2, 2021
- Fujifilm unveils the latest development roadmap for interchangeable lenses for the X Series of mirrorless digital cameras
- Sep 2, 2021
- Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business to PeptiDream
- Aug 31, 2021
- Launch of Therapeutic Radiopharmaceutical Product, Lutathera® Injection targeting neuroendocrine tumors in Japan (FUJIFILM Toyama Chemical)
- Jul 6, 2021
- FUJIFILM Holdings adopts a “DX Vision” (FUJIFILM Holdings)
- Jun 29, 2021
- $850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity
- Jun 23, 2021
-
Marketing Authorization Granted for Lutathera® Injection in Japan
- The first approval in Japan for peptide receptor radionuclide treatment drug, providing a new therapeutic option for neuroendocrine tumors (FUJIFILM Toyama Chemical) - May 27, 2021
- FUJIFILM Wako Pure Chemical launches “E484Q mutation detection kit” reagent for detecting a SARS-CoV-2 mutation (FUJIFILM Wako Pure Chemical)
- May 17, 2021
- FUJIFILM Wako Pure Chemical launches mutation detection kit for SARS-CoV-2 “L452R” (FUJIFILM Wako Pure Chemical)